The company will exhibit a wide-array of devices, including the Axle line of interspinous fusion systems, the Zyfix Facet Fusion System and the Silex Sacroiliac Joint Fusion System, which were all released in the past year.
X-spine currently markets its products in 30 countries and is looking to enter Asia. “Entering the Chinese market is a major commitment for any medical device company. However we feel that the economics and demographics of the Chinese market are becoming favorable to specialized device companies with leading technologies. It’s a natural progression of our market strategy to treat spinal disease on a global basis,” said X-spine’s CEO David Kirschman, MD.
More articles on devices:
Stryker Spine to launch ALIF technology at NASS
Integra LifeSciences introduces demineralized bone matrix strip implants for spine fusion
K2M’s CAPRI Corpectomy Cage System receives FDA clearance
